
    
      This study is a randomized, prospective, double-blind (blinded observer) , saline
      solution-controlled, parallel experimental design. The study device is SUPARTZ (Seikagaku
      Corporation, Tokyo, Japan) a brand of sodium hyaluronate.
    
  